Medifast Reports $17.5 Million Third Quarter Loss

The Baltimore-based company announced a $72 million revenue figure for the quarter ending in September.

Updated on Oct. 26, 2026 in Economic Indicators

Isometric editorial illustration featuring a heavy steel beam resting on a stone plinth, symbolizing corporate financial contraction. — Medifast reported a net loss of $17.5 million on $72 million in revenue for the third quarter of 2026. AI Illustration. Upload story photo >

Live Poll

Do you trust the long-term outlook for traditional weight-loss companies?

Medifast Inc. reported a net loss of $17.5 million for the third quarter of 2026. The company recorded $72 million in revenue during this three-month period.

Why it matters

The company is navigating a period of financial contraction as it adjusts its outlook for the remainder of the fiscal year. These figures offer insight into the current operational performance of the health and wellness provider.

Medifast reported a quarterly revenue of $72 million and a loss per share of $1.57. These figures are contrasted by an adjusted loss per share of 19 cents for the same period.

The players

Medifast Inc.

This Baltimore-based health and wellness company specializes in weight loss programs and nutrition products.

The details

The results for the three-month period ending in September reflect the financial position of the Baltimore-based firm as it heads into the final months of the year. Management has provided updated guidance for the upcoming fourth quarter.

Medifast reported these financial results for the third quarter of 2026.
The current fiscal quarter is scheduled to conclude in December 2026.

Macro View

This earnings report follows the standard disclosure patterns established by the 2026 fiscal year corporate earnings cycle. These results reflect broader adjustments in consumer spending that have mirrored historical volatility in the wellness sector.

The company's performance and future revenue projections influence the stability of their service offerings for current customers. Investors and clients should monitor the upcoming fourth quarter results for indicators of long-term operational recovery.

The takeaway

Medifast expects full-year revenue to land between $280 million and $300 million with a projected loss between 45 and 70 cents per share. Investors should look to the projected fourth quarter revenue of $55 million to $75 million for signs of stabilization.